Biomarkers in Prostate Cancer: Why They are Important
Awareness is very important with all cancers. The earlier the cancer is diagnosed, the more likely that that cancer is curable. One of the ways to improve diagnoses is with the use of biomarkers.
Dr. Martin Gleave
Distinguished Professor and Chair, Department of Urologic Sciences at UBC, and British Columbia Leadership Chair.
Director of the Vancouver Prostate Centre.
Don Konantz
Age 60 (Diagnosed with advanced prostate cancer at 48)
To learn more about prostate cancer biomarkers please speak with your healthcare provider.
Made possible through financial support from one of the Canada’s leading research-based pharmaceutical companies.
Click here to view Prostate Cancer: Understanding PSMA & Why It Matters